Dr. Kjell Van Royen SRL
Dr. Kjell Van Royen reported total assets of 282,056 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Mar 2026).
The score of Dr. Kjell Van Royen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -98 % Total assets +8 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Kjell Van Royen's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 247,261 € | ||||
| Equity | 3,000 € | ||||
| Cash | 196,482 € | ||||
| EBITDA | 337,657 € | ||||
| Total assets | 282,056 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Mar 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jul 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
Dr. Kjell Van Royen's financial analysis
- Solvency1.1%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Kjell Van Royen
Dr. Kjell Van Royen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.428.629
- VAT number
- BE0760428629
- Peppol
- Registered · 0208:0760428629 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 2020
- Registered office
- 1730 Asse
- Latest accounts
- 2025 · filed on 06 Mar 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Kjell Van Royen (SRL) has been based in Asse since 2020, active in: medical specialists activities. For 2025, it reports a net profit of 247,261 € and equity of 3,000 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Kjell Van Royen
Companies in the same business, of comparable size and area, outside its group.
- Mind AF Medical specialists activities Duffel · balance sheet 19 €
- Dr.Peter HEINEN Medical specialists activities Sankt Vith · balance sheet 282,107 €
- MediDeferm Medical specialists activities Begijnendijk · balance sheet 280,350 €
- Versalix Medical specialists activities Keerbergen · balance sheet 285,937 €
- Dr. Ann Janssen Medical specialists activities Maasmechelen · balance sheet 292,357 €
- Koen Norga Kinderarts Medical specialists activities Aarschot · balance sheet 271,262 €
- Dr. Bassens en Dr. Serlet Medical specialists activities Aalter · balance sheet 294,517 €
- Spoedconsult Medical specialists activities Grimbergen · balance sheet 265,100 €
Frequently asked questions about Dr. Kjell Van Royen
What is the revenue of Dr. Kjell Van Royen?
Dr. Kjell Van Royen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Kjell Van Royen?
In Belgium, the VAT number is the company number prefixed with BE: BE0760428629 for Dr. Kjell Van Royen, if the company is VAT-registered. Its company number (CBE) is 0760.428.629.
Where is the registered office of Dr. Kjell Van Royen?
According to the CBE register, the registered office of Dr. Kjell Van Royen is in 1730 Asse.
What is the equity of Dr. Kjell Van Royen?
At the close of the 2025 financial year, the equity of Dr. Kjell Van Royen amounts to 3,000 €, a solvency of 1.1% of total assets.
Who manages Dr. Kjell Van Royen?
The register lists 1 active mandates at Dr. Kjell Van Royen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Kjell Van Royen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →